Two Sigma Securities’s CorMedix CRMD Stock Holding History

Two Sigma Securities’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,326	Closed	-$165K	–	1838
2026 Q1	$165K	Buy	+24,326	New	+$180K	0.02%	1089
2024 Q1	–	Sell	-22,244	Closed	-$83.6K	–	3063
2023 Q4	$83.6K	Buy	+22,244	New	+$76.5K	﹤0.01%	2542
2021 Q2	–	Sell	-10,840	Closed	-$108K	–	1519
2021 Q1	$108K	Buy	+10,840	New	+$114K	0.01%	691
2018 Q2	–	Sell	-15,764	Closed	-$14K	–	2690
2018 Q1	$14K	Buy	+15,764	New	+$31.5K	﹤0.01%	2592

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Two Sigma Securities's CRMD Position: Q2 2026 in Review

Two Sigma Securities sold out of CorMedix (CRMD) in Q2 2026, closing a stake of 24,326 shares — an estimated $165K sold.

Two Sigma Securities first reported a position in CRMD in Q1 2018 and held it in 4 quarters. The position peaked at $165K in Q1 2026. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Two Sigma Securities reported no remaining CorMedix position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 24,326 CorMedix shares in Q2 2026, an estimated $165K.
Two Sigma Securities first reported a position in CorMedix in Q1 2018 and held it in 4 quarters.
Two Sigma Securities's CorMedix position peaked at $165K in Q1 2026.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.